11. Long-Acting Muscarinic Antagonists in Asthma and COPD

  1. Jan Lötvall
  1. M. Diane Lougheed1,
  2. Josuel Ora2 and
  3. Denis E. O'Donnell3

Published Online: 29 FEB 2012

DOI: 10.1002/9781119998624.ch11

Advances in Combination Therapy for Asthma and COPD

Advances in Combination Therapy for Asthma and COPD

How to Cite

Lougheed, M. D., Ora, J. and O'Donnell, D. E. (2012) Long-Acting Muscarinic Antagonists in Asthma and COPD, in Advances in Combination Therapy for Asthma and COPD (ed J. Lötvall), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119998624.ch11

Editor Information

  1. Krefting Research Centre, University of Gothenburg, Göteborg, Sweden

Author Information

  1. 1

    Department of Medicine, Division of Respirology, Queen's University, 102 Stuart Street, Kingston, Ontario, Canada, K7L 2V6

  2. 2

    Clinical Research Fellow, Respiratory Investigation Unit, Kingston General Hospital and Queen's University, 102 Stuart Street, Kingston, Ontario K7L 2V6, Canada

  3. 3

    Department of Medicine, Division of Respirology, Queen's University, 102 Stuart Street, Kingston, Ontario K7L 2V6, Canada

Publication History

  1. Published Online: 29 FEB 2012
  2. Published Print: 3 FEB 2012

ISBN Information

Print ISBN: 9780470727027

Online ISBN: 9781119998624

SEARCH

Keywords:

  • long-acting muscarinic antagonists;
  • asthma and COPD, chronic respiratory diseases;
  • airway innervation;
  • cholinergic mechanisms;
  • obstructive lung diseases;
  • long-acting anticholinergics, in COPD;
  • severe/persistent asthma;
  • cholinergic mechanisms, bronchomotor;
  • muscarinic antagonist bronchodilator

Summary

This chapter contains sections titled:

  • Introduction

  • Innervation of the airways

  • Cholinergic mechanisms in asthma and COPD

  • Role of long-acting anticholinergic bronchodilators in obstructive lung disease

  • Summary

  • References